CAR-T Warning Refinements Coming Soon From US FDA

 
• By Michael McCaughan
  
Peter Marks said the warning about secondary malignancy in CAR-T therapies soon will be revised. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Drug Safety